Don’t Blame Pharmaceutical Companies – New York Times

Posted by on Nov 24th, 2016 and filed under Pharmaceutical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Don’t Blame Pharmaceutical Companies – New York Times

To the Editor:

The authors of “The U.S. Is Standing in the Way of Cheaper Drugs for the Poor” (Opinion, Oct. 27) argue that eliminating patent protections on innovative biopharmaceuticals will improve access to medicines.

Yet there is no panacea for this complex issue, which is why the United States and other governments were skeptical of the United Nations’ sole focus on International Pharmaceuticals. This is especially concerning as off-patent medicines represent over 90 percent of the World Health Organization’s essential drugs, yet millions still lack access. Tackling the real global barriers to access would include addressing a lack of health care professionals, inadequate infrastructure, appropriate distribution systems and clean water.

The world’s innovative biopharmaceutical companies are deeply engaged in finding holistic solutions to access, partnering in more than 250 programs around the world that enable people to gain access to the full range of health care solutions.

The truth is that patients cannot receive new medicines unless they are invented. A holistic approach, where industry collaborates with governments, NGOs, and bodies like the United Nations and W.H.O. is much more productive than blaming pharmaceutical companies.

STEVE UBL

Washington

The writer is president and C.E.O. of Pharmaceutical Research and Manufacturers of America (PhRMA).

Continue reading the main story

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.